BETHESDA, Md., Oct. 23, 2024 /PRNewswire/ -- The National Institutes of Health (NIH) has launched a proof-of-concept precision medicine clinical trial to test new treatment combinations targeting specific genetic changes in the cancer cells of people with acute myeloid leukemia (AML) and...
NIH clinical trial will test precision medicine treatments for myeloid cancers
Seaking AlphaSeeking Alpha / Seaking Alpha 3 hours ago 1 Views
Comments